Cerus Corporation
CERS
#7713
Rank
S$0.57 B
Marketcap
S$2.87
Share price
-0.88%
Change (1 day)
40.35%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): S$1.57 Million

According to Cerus Corporation's latest financial reports the company's current earnings are S$0.22 Billion. In 2025 the company made an earning of -S$8.91 Million, an increase over its 2024 earnings that were of -S$15.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$1.57 M-117.69%
2025 -S$8.91 Million-41.58%
2024 -S$15.24 Million-58.95%
2023 -S$37.11 Million-20.74%
2022 -S$46.82 Million-25.7%
2021 -S$63.02 Million-11.99%
2020 -S$71.6 Million-14%
2019 -S$83.26 Million21.73%
2018 -S$68.39 Million-0.65%
2017 -S$68.84 Million-10.96%
2016 -S$77.32 Million4.24%
2015 -S$74.17 Million50.99%
2014 -S$49.13 Million-10.08%
2013 -S$54.64 Million184.13%
2012 -S$19.23 Million-7.91%
2011 -S$20.88 Million
2009 -S$29.49 Million-24.69%
2008 -S$39.16 Million-25.2%
2007 -S$52.35 Million330.54%
2006 -S$12.16 Million1.49%
2005 -S$11.98 Million-61.02%
2004 -S$30.74 Million
2002 -S$76.03 Million10.02%
2001 -S$69.1 Million34.25%
2000 -S$51.47 Million61.02%
1999 -S$31.97 Million-18.81%
1998 -S$39.38 Million93.08%
1997 -S$20.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.79 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
S$16.52 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
S$0.20 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$21.19 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA